How Big Pharma donations can influence public drug coverage

Professor Emeritus Joel Lexchin of  University of Toronto & York University examines in his study, in PLoS One, whether drug company donations influence patient group views – and found many conflicts of interest alongside lobbying for public drug plans to pay.